| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2022 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 3,600 | $139.50 | $502,200.00 | -7.7% | +7.7% | -27.0% | |
| Nov 1, 2022 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,704 | $25.49 | $196,386.18 | -1.8% | +1.2% | -39.2% | |
| Nov 1, 2022 | MEDP Medpace Holdings, Inc. | Kraft Robert O.51 | Director | Sell | 9,630 | $221.42 | $2,132,274.60 | -100% | -3.4% | +13.2% | |
| Nov 1, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $514.39 | $10,287,890.82 | -0.5% | +9.1% | -14.7% | |
| Oct 27, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.82 | $182,005.84 | - | -27.5% | -31.7% | |
| Oct 27, 2022 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Sell | 6,500 | $220.53 | $1,433,445.00 | -30.4% | +5.6% | +15.8% | |
| Oct 26, 2022 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 6,775 | $134.43 | $910,763.25 | -3.4% | +13.1% | -24.2% | |
| Oct 26, 2022 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 1,994 | $1.02 | $2,033.48 | -10.9% | -64.2% | -91.3% | |
| Oct 25, 2022 | DHR Danaher Corp /de/ | Spoon Alan G55 | - | Sell | 500 | $252.93 | $126,465.00 | -0.5% | +10.0% | -23.5% | |
| Oct 25, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,958 | $20.46 | $183,318.81 | -0.7% | +23.4% | -42.1% | |
| Oct 25, 2022 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 379 | $29.55 | $11,199.45 | -0.1% | -7.9% | -50.9% | |
| Oct 24, 2022 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 350 | $42.41 | $14,843.64 | -0.2% | +1.3% | -4.4% | |
| Oct 24, 2022 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,488 | $42.41 | $105,517.32 | -2.7% | +1.3% | -4.4% | |
| Oct 24, 2022 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 44 | $42.41 | $1,866.01 | - | +1.3% | -4.4% | |
| Oct 24, 2022 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 3,135 | $42.41 | $132,956.60 | -38.9% | +1.3% | -4.4% | |
| Oct 24, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 905 | $42.41 | $38,381.41 | -1.2% | +1.3% | -4.4% | |
| Oct 20, 2022 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 5,412 | $0.89 | $4,818.30 | -5.3% | -50.3% | -89.4% | |
| Oct 19, 2022 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 6,775 | $130.11 | $881,495.25 | -3.4% | +20.5% | -15.1% | |
| Oct 19, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.72 | $172,069.24 | - | -8.1% | -26.0% | |
| Oct 17, 2022 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Sell | 1,000 | $19.10 | $19,100.00 | -1.5% | -56.5% | -87.5% | |
| Oct 17, 2022 | WGS Genedx Holdings Corp. | Ryan Jason65 | Executive Chairman | Sell | 1,281 | $0.86 | $1,101.40 | -7.5% | -48.8% | -89.1% | |
| Oct 14, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.72 | $171,917.36 | - | -23.1% | -22.0% | |
| Oct 13, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.79 | $179,367.31 | - | -26.4% | -24.2% | |
| Oct 12, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.73 | $172,722.41 | - | -27.0% | -20.7% | |
| Oct 12, 2022 | EXAS Exact Sciences Corp | Cunningham Everett54 | Chief Commercial Officer | Sell | 16,872 | $31.37 | $529,274.64 | -47.5% | +90.0% | +104.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.